Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
Primary objective:
- To evaluate the rate of responses to neoadjuvant therapy + radiotherapy
Secondary objective:
- tolerability (toxicity) and time to progression